ATACAND is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ani Pharmaceuticals, Inc.. The primary component is Candesartan Cilexetil.
Product ID | 62559-642_690e8be9-d5c7-457b-a24e-9f5479d63562 |
NDC | 62559-642 |
Product Type | Human Prescription Drug |
Proprietary Name | ATACAND |
Generic Name | Candesartan Cilexetil |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020838 |
Labeler Name | ANI Pharmaceuticals, Inc. |
Substance Name | CANDESARTAN CILEXETIL |
Active Ingredient Strength | 16 mg/1 |
Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020838 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-10-01 |
Marketing Category | NDA |
Application Number | NDA020838 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-10-01 |
Ingredient | Strength |
---|---|
CANDESARTAN CILEXETIL | 16 mg/1 |
SPL SET ID: | 94a59260-d2b6-464a-b5b9-bbc599e57e10 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0186-0004 | ATACAND | Candesartan cilexetil |
0186-0008 | ATACAND | Candesartan cilexetil |
0186-0016 | ATACAND | Candesartan cilexetil |
0186-0032 | ATACAND | Candesartan cilexetil |
68151-4146 | ATACAND | ATACAND |
68151-4145 | ATACAND | ATACAND |
62559-643 | ATACAND | ATACAND |
62559-641 | ATACAND | ATACAND |
62559-642 | ATACAND | ATACAND |
62559-640 | ATACAND | ATACAND |
63629-3376 | ATACAND | ATACAND |
0378-3224 | candesartan cilexetil | candesartan cilexetil |
0378-3225 | candesartan cilexetil | candesartan cilexetil |
0378-3231 | candesartan cilexetil | candesartan cilexetil |
0378-3232 | candesartan cilexetil | candesartan cilexetil |
0781-5936 | Candesartan cilexetil | Candesartan cilexetil |
0781-5937 | Candesartan cilexetil | Candesartan cilexetil |
0781-5938 | Candesartan cilexetil | Candesartan cilexetil |
0781-5939 | Candesartan cilexetil | Candesartan cilexetil |
46708-060 | CANDESARTAN CILEXETIL | CANDESARTAN CILEXETIL |
46708-341 | CANDESARTAN CILEXETIL | CANDESARTAN CILEXETIL |
46708-342 | CANDESARTAN CILEXETIL | CANDESARTAN CILEXETIL |
46708-343 | CANDESARTAN CILEXETIL | CANDESARTAN CILEXETIL |
49884-658 | Candesartan cilexetil | Candesartan cilexetil |
49884-659 | Candesartan cilexetil | Candesartan cilexetil |
49884-660 | Candesartan cilexetil | Candesartan cilexetil |
49884-661 | Candesartan cilexetil | Candesartan cilexetil |
60687-119 | Candesartan cilexetil | Candesartan cilexetil |
60687-130 | Candesartan cilexetil | Candesartan cilexetil |
60687-241 | Candesartan cilexetil | Candesartan cilexetil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ATACAND 75477028 not registered Dead/Abandoned |
ASTRA AB 1998-04-30 |
ATACAND 75033908 2160791 Live/Registered |
AstraZeneca AB 1995-12-18 |